Valuation: EUROAPI

Market Cap 12Cr 13Cr 11Cr 9.99Cr 19Cr 1.28TCr 19Cr 129.3Cr 51Cr 631.13Cr 50Cr 49Cr 2.18TCr P/E 2026 *
-1.54x
P/E 2027 * -2.91x
Enterprise Value 7.54Cr 8.59Cr 7.01Cr 6.44Cr 12Cr 826.94Cr 12Cr 83Cr 33Cr 406.55Cr 32Cr 32Cr 1.41TCr EV / Sales 2026 *
0.1x
EV / Sales 2027 * 0.14x
Free-Float
65.03%
Yield 2026 *
-
Yield 2027 * -
1 day+0.33%
1 week-3.45%
Current month-7.80%
1 month-6.11%
3 months-3.76%
6 months-43.42%
Current year-45.81%
1 week 1.21
Extreme 1.214
1.29
1 month 1.21
Extreme 1.214
1.39
Current year 1.21
Extreme 1.214
2.28
1 year 1.21
Extreme 1.214
3.44
3 years 1.21
Extreme 1.214
12.97
5 years 1.21
Extreme 1.214
19.02
10 years 1.21
Extreme 1.214
19.02
Manager TitleAgeSince
Chief Executive Officer - 09/12/2024
Director of Finance/CFO - 17/10/2024
Compliance Officer - 27/11/2023
Director TitleAgeSince
Director/Board Member 62 06/05/2022
Director/Board Member - 06/05/2022
Chairman 57 09/12/2024
Date Insider Type Main position Quantity % Market Cap.
01/06/23 Buy

Chief Financial Officer

617 0.0007%
01/06/23 Buy

Chief Financial Officer

635 0.0007%
01/06/23 Buy

Chief Financial Officer

617 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%-3.45%-61.08%-88.54% 13Cr
+0.86%+1.43%+47.17%+161.40% 1,06700Cr
+1.59%+4.09%+56.51%+52.79% 63TCr
+0.95%+1.91%+36.30%+83.13% 46TCr
+1.60%+6.25%+37.00%+30.00% 35TCr
-0.60%+1.52%+36.67%+39.80% 30TCr
-0.14%+0.60%+17.29%+18.19% 26TCr
+0.09%-2.82%-29.09%-41.29% 22TCr
+1.22%+2.66%+22.66%+59.81% 20TCr
-1.18%-3.70%+11.28%+67.43% 16TCr
Average +0.47%+0.85%+17.47%+38.27% 36.44TCr
Weighted average by Cap. +0.76%+1.95%+35.99%+78.14%

Financials

2026 *2027 *
Net sales 76Cr 87Cr 71Cr 65Cr 121.93Cr 8.34TCr 123.81Cr 839.8Cr 328.1Cr 4.1TCr 325.04Cr 318.03Cr 14TCr 78Cr 89Cr 73Cr 67Cr 125.32Cr 8.57TCr 127.25Cr 863.11Cr 337.21Cr 4.21TCr 334.06Cr 326.86Cr 15TCr
Net income -7.57Cr -8.62Cr -7.04Cr -6.46Cr -12Cr -830.03Cr -12Cr -84Cr -33Cr -408.07Cr -32Cr -32Cr -1.41TCr -4.03Cr -4.58Cr -3.74Cr -3.44Cr -6.45Cr -441.35Cr -6.55Cr -44Cr -17Cr -216.98Cr -17Cr -17Cr -750.23Cr
Net Debt -4.17Cr -4.74Cr -3.87Cr -3.56Cr -6.68Cr -456.8Cr -6.78Cr -46Cr -18Cr -224.58Cr -18Cr -17Cr -776.48Cr -50.63L -57.65L -47.09L -43.21L -81.19L -56Cr -82.44L -5.59Cr -2.18Cr -27Cr -2.16Cr -2.12Cr -94Cr
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
24/26/24 €1.230 +0.33% 46,177
23/26/23 €1.226 -2.70% 64,601
22/26/22 €1.260 -1.10% 77,906
21/26/21 €1.274 +0.79% 86,824
20/26/20 €1.264 -0.78% 85,802
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
1.230EUR
Average target price
1.475EUR
Spread / Average Target
+19.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EAPI Stock